Series D funding
China Becomes New Hunting Ground for Obesity Drugs
Corxel’s latest funding round lands at a time when U.S. and European drug developers are increasingly sourcing new medicines from China. Over the past few years, both large pharmaceutical companies and venture-backed biotech firms have shown a willingness to license compounds discovered in Chinese labs and move them quickly into Western clinical programs. That strategy…
